Understanding the Tax Implications of Startup Equity

1. Why Taxes Can Make or Break Your Equity Decision

Many startup employees are surprised to learn that taxes on stock options often arise long before any liquidity event. Whether you’re exercising options in the U.S., Israel, or elsewhere, understanding the tax landscape is essential to avoid unexpected costs — and to structure your equity decisions wisely.

The type of options you hold, how and when you exercise, and where you live all influence your tax exposure. This article outlines the key factors to consider before making any moves.

2. Types of Equity and Their Tax Treatment

Before diving into tax mechanics, it’s important to understand what kind of equity you hold. The tax rules vary widely depending on whether you have:

• Incentive Stock Options (ISOs) – U.S.-based, potentially favorable tax treatment
• Non-Qualified Stock Options (NSOs) – Taxed as ordinary income when exercised
• Restricted Stock Units (RSUs) – Taxed at vesting
• Options under Section 102 (Israel) – Often held in trust with deferred taxation

Each structure comes with distinct tax consequences. Let’s look more closely at two common jurisdictions: the United States and Israel.

3. U.S. Employees: What You Need to Know

Incentive Stock Options (ISOs):

• If you exercise ISOs and hold the shares for at least one year (and two years from grant), you may qualify for long-term capital gains.
• However, exercising ISOs can trigger Alternative Minimum Tax (AMT) in the year you exercise.
• If the company’s valuation drops after you exercise, you could owe tax on “phantom gains” — even if your shares decline in value.

Non-Qualified Stock Options (NSOs):

• Taxed as ordinary income at the time of exercise, based on the difference between the strike price and the fair market value.
• This tax is due whether or not you sell the shares.

Key Consideration:

In both cases, taxes may be owed even if you never sell your shares. That’s why understanding the company’s 409A valuation and market prospects is essential.

4. Israeli Employees: Section 102 and Trusteeship

In Israel, many employee stock options are issued under Section 102 of the Income Tax Ordinance, which provides certain tax benefits if structured correctly.

Key features of Section 102 (Capital Gains Track):

• Options are held in trust for 24 months.
• If structured properly, taxes are deferred until sale — and gains may be taxed as capital gains (25%), not salary (up to 50%+).
• Early sale or improper handling can result in higher income tax liability.

Important:
If your options are not held in trust, or if you leave the company and transfer them prematurely, the favorable treatment may be lost.

Trustees (e.g., IBI, AltShare, ESOP) help manage this process and maintain eligibility under Section 102 — but it’s your responsibility to understand your status and confirm that all filings are compliant.

5. Cross-Border Tax Considerations

Many employees live in one country but hold equity in a company based in another — or move between jurisdictions during their employment. This can create dual-tax exposure.

For example:

• An Israeli employee working at a U.S. startup may owe Israeli tax upon sale and still face U.S. withholding depending on tax treaties.
• A U.S. taxpayer exercising foreign options may need to report income under both U.S. tax law and local rules — and may face penalties for non-disclosure.

Recommendation:

If you hold equity across borders or plan to relocate, speak with a cross-border tax advisor before exercising or selling. Missteps can be costly and difficult to unwind.

6. Timing Matters: When You Exercise Impacts Tax

The timing of your exercise can dramatically affect how much you owe. Some key timing considerations include:

• Early Exercise: Can start long-term capital gains clock sooner, but increases risk if the company fails.
• Late Exercise: May be safer if a liquidity event is imminent, but may trigger higher taxes.
• Leaving the Company: You may only have 60-90 days to exercise after termination, compressing your decision window.

Additionally, certain tax elections (e.g. 83(b) in the U.S.) must be filed within strict timelines. Missing a deadline can limit your options and increase your tax bill.

7. Tax Strategies to Strive to Reduce Risk

There are several ways to manage or mitigate the tax burden:

• Option Financing: A third party pays the exercise cost and taxes in exchange for a share of future gains. This can reduce your out-of-pocket risk.
• Secondary Sale: Selling a portion of your equity (if permitted) can help you cover taxes while retaining upside.
• Pooling or Diversification: Spread risk by combining equity positions or participating in equity pools.

Each solution has trade-offs and eligibility requirements, so it’s important to match the right strategy with your equity structure and goals.

Final Thoughts: Don’t Let Taxes Catch You Off Guard

Startup equity can be a life-changing asset — or a costly misstep. The difference often lies in tax planning. Before you exercise or sell, make sure you understand:

• What kind of equity you have
• How and when it will be taxed
• How local and international tax laws apply
• What strategies you can use to attempt to protect your position

At The Elephant, we help employees, founders, and shareholders understand their equity — including access to real-world valuation data, liquidity options, and risk mitigation tools.

Neither this article nor Elephant provides any tax advice and may not be relied on. You are requested to consult with your independent tax advisor on your specific circumstances.

Important Disclosures:

For more information on Emerson Equity, please visit FINRA’s BrokerCheck website. You can also download a copy of Emerson Equity’s Customer Relationship Summary to learn more about their role and services.
The contents of this communication: (i) do not constitute an offer of securities or a solicitation of an offer to buy securities, (ii) are insufficient to rely upon to make an investment decision, and you should seek to obtain a current Private Placement Memorandum (the “PPM”) for the offering which is typically available upon request from the issuer, (iii) do not and cannot replace the PPM and is qualified in its entirety by the PPM, and (iv) may not be relied upon in making an investment decision related to any investment offering by the issuer, or any affiliate, or partner thereof (“Issuer”). All potential investors should read the PPM.
With respect to any “targeted” goals and performance levels outlined herein, these do not constitute a promise of performance, nor is there any assurance that the investment objectives of any program will be attained. Further, any “negative news” information provided is based upon reasonable search of publicly available information. We do not guarantee the accuracy or completeness of such information. In addition to the news and summaries made available on this platform, you should always conduct your own additional due diligence through publicly available resources. The information provided herein is not necessarily exhaustive and additional information, whether positive or negative, may exist that is not covered by the scope of that provided here.
All investments carry the risk of loss of some or all of the principal invested. Any “targeted” factors are based upon reasonable assumptions more fully outlined in the Offering Documents/PPM for the respective offering. Consult the PPM for investment conditions, risk factors, minimum requirements, fees and expenses and other pertinent information with respect to any investment. These investment opportunities have not been registered under the Securities Act of 1933 and are being offered pursuant to an exemption therefrom and from applicable state securities laws. All offerings are intended only for accredited investors unless otherwise specified. Past performance is no guarantee of future results. All information is subject to change. You should always consult a tax professional prior to investing. Investment offerings and investment decisions should only be made on the basis of a confidential private placement memorandum issued by Issuer, or one of its partner/issuers. Issuer does not warrant the accuracy or completeness of the information contained herein. Thank you for your cooperation.
Securities through Emerson Equity LLC Member: FINRA/SIPC. Only available in states where Emerson Equity LLC is registered. Emerson Equity LLC is not affiliated with any other entities identified in this communication.